Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Pollinex Quattro Ragweed: Phase III

July 30, 2007 7:00 AM UTC

AGY reported that the Phase III R301 trial of Pollinex Quattro Ragweed vaccine is "highly unlikely" to meet its primary endpoint of combined symptom and medication score. AGY said it now will be requi...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article